Whalegun
Lobbying

Globe Life GL's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q3 2023; the issues it reports most are Taxation/Internal Revenue Code and Medical/Disease Research/Clinical Labs.

Globe LifeGL

Globe Life stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$180K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q3 2023
The first quarter a report named it

Lobbying by quarter

Globe Life lobbying by quarter
Globe Life lobbying by quarter
QuarterAmountReports
Q3 2023$20K1
Q4 2023$60K1
Q1 2024$60K1
Q2 2024$60K1
Q3 2024$60K1
Q4 2024$60K1
Q1 2025$60K1
Q2 2025$60K1
Q3 2025$60K1
Q4 2025$60K1
Q1 2026$60K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Taxation$570K · 10 reports
  • Medical research and clinical labs$30K · 1 reports
  • Insurance$20K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES11 reports
  • SENATE11 reports

Firms it paid

Firm
Troutman Strategies$360K6 quarters
Locke Lord$320K6 quarters

Former officials lobbying for it

Former position
JASON ZANETTINONEQ2 2026

Lobbying reports

Filed by
07/20for Q2Troutman Strategies$60K
04/20for Q1Troutman Strategies$60K
01/15for Q4 2025Troutman Strategies$60K
25/10/16for Q3 2025Troutman Strategies$60K
25/07/18for Q2 2025Troutman Strategies$60K
25/04/09for Q1 2025Troutman Strategies$60K
25/01/16for Q4 2024Locke Lord$60K
25/01/16for Q1 2025Troutman StrategiesUnder $5,000
24/10/21for Q3 2024Locke Lord$60K
24/07/22for Q2 2024Locke Lord$60K
24/04/22for Q1 2024Locke Lord$60K
24/01/22for Q4 2023Locke Lord$60K
23/10/20for Q3 2023Locke Lord$20K
23/09/13for Q3 2023Locke LordUnder $5,000